Radiopharm Theranostics

RADX

----

H2 2026 Earnings

Financial report interval: 2025.12.30 - 2026.06.30

Overview: Radiopharm Theranostics(RADX) the Revenue is 994.35 K (-32.27%), Beat estimate;the EBIT is -20.67 M (-70.04%), Miss estimate;the EPS is -1.54 (-5.14%), Miss estimate.

Actual

YoY

Estimate

YoY

Vs estimate

YoY

RevenueExceed expectations

0.00B32.27%

0.00B61.64%

+0.00B29.37%

EBITMiss expectations

-0.02B70.04%

-0.02B41.82%

-0.00B28.22%

EPSMiss expectations

-1.53625.14%

-1.297511.20%

-0.238716.34%

Upcoming earnings report - Q1 FY2027

Available dateNov 26, 2026

Estimate Revenue--

Estimate EBIT--

Estimate EPS--

Revenue

ActualEstimateUnit: USD

Quarterly

EBIT

ActualEstimateUnit: USD

Quarterly

Net income

ActualEstimateUnit: USD

Quarterly

EPS

ActualEstimateUnit: USD

Quarterly